市場調查報告書
商品編碼
1390591
2023-2028 年按疾病類型、測試類型、服務和地區分類的家禽診斷市場報告Poultry Diagnostics Market Report by Disease Type, Test Type, Service, and Region 2023-2028 |
2022年,全球家禽診斷市場規模達到4.418億美元。展望未來, IMARC Group預計到2028年市場規模將達到7.912億美元,2022-2028年複合年成長率(CAGR)為10.20%。家禽消費量的增加、禽流感和新城疫的頻繁爆發、嚴格的食品安全法規、重大的技術進步、對家禽疫情相關經濟損失的認知不斷提高以及該領域持續的研究和開發活動是推動這一領域發展的一些關鍵因素。市場。
家禽診斷是家禽業的一個重要方面,重點是識別和管理家禽群中的疾病和健康問題。它在確保家禽的健康方面發揮關鍵作用,反過來又保障了消費者家禽產品的品質。這些診斷涵蓋一系列技術,包括實驗室測試、臨床檢查和先進的影像技術。家禽診斷的主要目標是及時發現和解決疾病,例如禽流感、新城疫和球蟲病等。早期檢測對於防止疾病在雞群內傳播、減少經濟損失和維持食品安全標準至關重要。此外,它有助於制定有效的疫苗接種和治療策略。
全球對家禽產品的需求不斷成長,作為負擔得起的瘦肉蛋白質來源,這是一個主要驅動力。消費量的激增需要強力的診斷,以確保家禽群的健康和安全。此外,禽流感、新城疫等疾病的頻繁爆發,也凸顯了家禽生產的脆弱性。這導致對診斷工具的更多投資,以快速識別和控制疾病。除此之外,家禽生產者越來越意識到與疾病爆發相關的經濟損失。這種意識促使他們投資於主動診斷措施,以保護他們的羊群和利潤。除此之外,世界各國政府正在對食品安全(包括家禽產品)執行更嚴格的法規。家禽診斷對於遵守這些法規和維持消費者信任至關重要。與此一致的是,PCR和ELISA等診斷技術的進步提高了疾病檢測的速度和準確性。這刺激了這些診斷方法在家禽業的採用。此外,家禽診斷領域正在進行的研究正在導致更複雜、更有效的診斷工具的開發,吸引投資和市場成長。
家禽消費量上升
雞和火雞等家禽是全球不斷成長的人口負擔得起的優質蛋白質的重要來源。隨著越來越多的人將家禽涵蓋飲食中,越來越需要確保家禽群的健康和安全以滿足這一需求。家禽診斷在維持這些家禽的健康方面發揮關鍵作用,這直接影響可供消費的家禽產品的品質和數量。健康的雞群生產力更高,不易爆發疾病,有助於提高家禽養殖業的整體效率。因此,家禽消費的成長與保護動物健康和食品安全的有效診斷需求有著內在的關聯。
疾病頻繁爆發
這些疾病可以在雞群中迅速傳播,對家禽生產者造成重大經濟損失。為此,家禽業已經認知到疾病的早期發現和管理的至關重要性。家禽診斷是快速識別導致這些疫情的病原體的存在不可或缺的工具。快速診斷可以及時實施檢疫和疫苗接種等控制措施,以遏制疾病傳播並限制經濟損失。疾病爆發可能導致家禽生產大規模中斷,這使得家禽診斷成為該行業永續發展的基本投資。
嚴格的食品安全法規
各國政府和監管機構越來越重視確保消費者家禽產品的安全。這包括監測和控制可從家禽傳播給人類的疾病。家禽診斷在滿足這些監管要求方面發揮關鍵作用。它們使家禽生產商能夠證明其遵守嚴格的健康和安全標準,確保家禽產品不含致病因子。不遵守這些規定可能會導致產品召回、法律後果以及公司聲譽受損。
IMARC Group提供了對市場報告各細分市場主要趨勢的分析,以及 2023 年至 2028 年全球、區域和國家層面的預測。我們的報告根據疾病類型、測試類型和服務對市場進行了分類。
禽流感
禽沙門氏菌病
禽支原體疾病
傳染性支氣管炎
傳染性法氏囊病
新城疫
雞貧血症
其他
禽流感佔大部分市場佔有率
該報告根據疾病類型對市場進行了詳細的細分和分析。這包括禽流感、禽沙門氏菌病、禽支原體病、傳染性支氣管炎、新城疫、雞貧血等。根據該報告,禽流感佔最大部分。
禽流感,俗稱禽流感,由於其高度傳染性和在家禽群內快速傳播的潛力,對全球家禽業構成重大威脅。這種增加的風險促使家禽生產者優先考慮禽流感診斷,作為保護其雞群的主動措施。此外,禽流感因其人畜共患的潛力(這意味著它可以從鳥類傳播給人類)而引起了各國政府和國際組織的廣泛關注。這種對動物和人類健康的雙重威脅導致了嚴格的監測和控制措施,進一步推動了對禽流感診斷的需求,以確保早期發現和遏制。此外,禽流感的爆發可能導致毀滅性的經濟損失,包括大規模撲殺受感染的鳥類、貿易限制以及消費者對家禽產品的信心下降。因此,禽流感爆發的經濟影響促使家禽生產商大力投資禽流感診斷,作為其風險緩解策略的一部分。
酵素連結免疫吸附試驗
PCR檢測
其他
ELISA檢測產業佔有率第一
報告中還提供了基於測試類型的詳細市場區隔和分析。這包括 ELISA 測試、PCR 測試等。報告顯示,ELISA檢測佔據最大的市場佔有率。
ELISA 以其在檢測多種家禽疾病(包括禽流感、新城疫和沙門氏菌病等)方面的多功能性和廣泛適用性而聞名。這種多功能性使其成為許多家禽生產商和診斷實驗室作為綜合診斷工具的首選。除此之外,ELISA 測試具有高靈敏度和特異性,確保結果準確可靠。家禽業非常重視精確的疾病檢測,以便及時做出明智的決策,例如啟動疾病控制措施或治療方案。此外,與其他一些診斷方法相比,ELISA 測試相對具有成本效益,這使其成為家禽生產商尋求有效疾病管理而不顯著增加營運成本的有吸引力的選擇。此外,ELISA 技術的成熟性質以及大量經過驗證的檢測方法,使行業專業人士和監管機構對其有效性充滿信心。對 ELISA 可靠性的信心及其成功疾病管理的記錄有助於其成為按測試類型分類的市場中最大的細分市場。
細菌學
寄生蟲學
病毒學
細菌學代表了領先的細分市場
該報告根據服務提供了詳細的市場細分和分析。這包括細菌學、寄生蟲學和病毒學。根據該報告,細菌學佔最大的部分。
細菌在家禽健康中發揮關鍵作用,因為細菌感染可以在雞群中迅速傳播並導致嚴重的經濟損失。細菌學服務包括分離、鑑定和表徵導致各種家禽疾病的細菌病原體。這包括沙門氏菌和大腸桿菌感染等常見問題,這些問題對家禽健康和食品安全都有重大影響。此外,食品安全法規和消費者對安全家禽產品的需求加劇了對家禽細菌病原體的關注。因此,家禽生產商和加工商嚴重依賴細菌學服務來確保其產品符合嚴格的安全標準並且不會對消費者構成健康風險。此外,細菌學的不斷研究和創新促進了先進診斷技術的發展,例如DNA定序和分子方法,這些技術提供了更高的特異性和靈敏度。這進一步鞏固了細菌學作為家禽診斷市場最大服務領域的地位,滿足了動物健康和公共衛生的關鍵需求。
北美洲
美國
加拿大
亞太
中國
日本
印度
韓國
澳洲
印尼
其他
歐洲
德國
法國
英國
義大利
西班牙
俄羅斯
其他
拉丁美洲
巴西
墨西哥
其他
中東和非洲
北美市場領先,佔據最大的家禽診斷市場佔有率
市場研究報告還對所有主要區域市場進行了全面分析,其中包括北美(美國和加拿大);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告稱,北美佔據最大的市場佔有率。
北美擁有完善且高度工業化的家禽業,美國是全球最大的家禽生產國之一。大量的家禽生產需要嚴格的疾病管理,以確保家禽群的健康和安全以及家禽產品的品質,從而產生了對診斷服務和工具的大量需求。此外,該地區非常重視食品安全和消費者健康。嚴格的監管框架和消費者對安全家禽產品的期望刺激了對先進診斷技術的投資,以有效檢測和管理疾病,從而支持家禽診斷市場的成長。除此之外,北美受益於成熟的醫療保健和獸醫基礎設施,促進了尖端診斷方法的採用。領先的診斷公司、研究機構和獸醫診所的存在進一步促進了該地區家禽診斷的可用性和利用。此外,北美對家禽業研發的積極態度確保了診斷技術的持續創新,並滿足該行業不斷變化的需求。
家禽診斷領域的領先公司正在大力投資研發。他們正在開發創新的診斷工具和技術,以提高疾病檢測的敏感度、特異性和速度。這種對創新的承諾確保家禽生產者能夠獲得最先進的診斷技術來保護他們的雞群。此外,許多主要參與者正在與研究機構和獸醫組織建立策略合作夥伴關係。這些合作促進了知識交流,從而發展了尖端的診斷解決方案。合作夥伴關係還有助於擴大市場範圍並確保先進診斷技術的廣泛採用。除此之外,認知到家禽業的全球性,主要參與者正在擴大在各個地區的業務。這包括建立分銷網路、建立子公司以及進入具有高家禽生產潛力的新興市場。透過在全球範圍內提供診斷產品和服務,這些公司正在利用家禽診斷不斷成長的需求。此外,根據家禽生產者的具體需求客製化診斷解決方案是一項值得注意的策略。主要參與者正在提供客製化的診斷包,以解決不同家禽養殖場面臨的獨特挑戰。這種方法可以提高客戶滿意度並促進長期合作夥伴關係。
農業生物泰克實驗室
生物化學公司
百奧諾特有限公司
勃林格殷格翰國際股份有限公司
IDEXX 實驗室公司
MEGACOR 診斷有限公司
凱傑公司
Gezondheidsdienst voor Dieren BV(皇家 GD)
賽默飛世爾科技公司
碩騰公司
(請注意,這只是關鍵參與者的部分列表,報告中提供了完整列表。)
2022 年,IDEXX Laboratories Inc 宣布推出一系列新的診斷測試以及新的軟體應用程式,以幫助農民和生產者管理家禽健康。它還引入了快速檢測方法和診斷分析,為家禽疾病提供快速、準確的結果。
Qiagen 是家禽診斷市場的領導者,致力於為家禽產業開發分子診斷解決方案。它推出了先進的基於 DNA 和 RNA 的測試來檢測家禽中的各種病原體和疾病。
Thermo Fisher Scientific Inc 一直積極參與家禽診斷市場。它開發了創新的解決方案,例如基於 PCR 的檢測試劑盒和先進的診斷儀器,以準確檢測家禽疾病。
The global poultry diagnostics market size reached US$ 441.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 791.2 Million by 2028, exhibiting a growth rate (CAGR) of 10.20% during 2022-2028. The rising poultry consumption, frequent outbreaks of avian influenza and Newcastle disease, stringent food safety regulations, significant technological advancements, growing awareness about the economic losses associated with poultry outbreaks, and ongoing research and development activities in this field are some of the key factors driving the market.
Poultry diagnostics is a crucial aspect of the poultry industry, focusing on the identification and management of diseases and health issues in poultry flocks. It plays a pivotal role in ensuring the well-being of poultry birds, which, in turn, safeguards the quality of poultry products for consumers. These diagnostics encompass a range of techniques, including laboratory tests, clinical examinations, and advanced imaging technologies. The primary objective of poultry diagnostics is to promptly detect and address diseases, such as avian influenza, Newcastle disease, and coccidiosis, among others. Early detection is vital to prevent the spread of diseases within flocks, reduce economic losses, and maintain food safety standards. Moreover, it aids in the development of effective vaccination and treatment strategies.
The increasing global demand for poultry products as a source of affordable and lean protein is a primary driver. This surge in consumption necessitates robust diagnostics to ensure the health and safety of poultry flocks. Additionally, frequent outbreaks of diseases like avian influenza and Newcastle disease have highlighted the vulnerability of poultry production. This has led to greater investments in diagnostic tools to quickly identify and contain diseases. Other than this, poultry producers are becoming increasingly aware about the economic losses associated with disease outbreaks. This awareness drives them to invest in proactive diagnostic measures to protect their flocks and bottom lines. Besides this, governments worldwide are enforcing stricter regulations on food safety, including poultry products. Poultry diagnostics are essential for compliance with these regulations and to maintain consumer trust. In line with this, advances in diagnostic technologies, such as PCR and ELISA, have enhanced the speed and accuracy of disease detection. This has spurred the adoption of these diagnostic methods in the poultry industry. Furthermore, ongoing research in the field of poultry diagnostics is leading to the development of more sophisticated and effective diagnostic tools, attracting both investments and market growth.
Rising Poultry Consumption
Poultry, such as chickens and turkeys, is a significant source of affordable and high-quality protein for a growing global population. As more people include poultry in their diets, there is a greater need to ensure the health and safety of poultry flocks to meet this demand. Poultry diagnostics play a critical role in maintaining the health of these birds, which directly impacts the quality and quantity of poultry products available for consumption. Healthy flocks are more productive and less prone to disease outbreaks, contributing to the overall efficiency of poultry farming operations. Therefore, the rise in poultry consumption is intrinsically linked to the demand for effective diagnostics to safeguard both animal health and food safety.
Frequent Disease Outbreaks
These diseases can spread rapidly within flocks, leading to significant economic losses for poultry producers. In response, the poultry industry has recognized the critical importance of early detection and management of diseases. Poultry diagnostics are indispensable tools for swiftly identifying the presence of pathogens responsible for these outbreaks. Rapid diagnosis allows for timely implementation of control measures, such as quarantine and vaccination, to contain the spread of the disease and limit economic losses. The potential for large-scale disruptions in poultry production due to disease outbreaks has made poultry diagnostics a fundamental investment for the sustainability of the industry.
Stringent Food Safety Regulations
Governments and regulatory bodies are placing greater emphasis on ensuring the safety of poultry products for consumers. This includes monitoring and controlling diseases that can be transmitted from poultry to humans. Poultry diagnostics play a pivotal role in meeting these regulatory requirements. They enable poultry producers to demonstrate compliance with strict health and safety standards, ensuring that poultry products are free from disease-causing agents. Failure to adhere to these regulations can result in product recalls, legal consequences, and damage to a reputation of a company.
IMARC Group provides an analysis of the key trends in each segment of the market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on disease type, test type, and service.
Avian Influenza
Avian Salmonellosis
Avian Mycoplasmosis
Infectious Bronchitis
Infectious Bursal Disease
Newcastle Disease
Chicken Anemia
Others
Avian Influenza accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the disease type. This includes avian influenza, avian salmonellosis, avian mycoplasmosis, infectious bronchitis, Newcastle disease, chicken anemia, and others. According to the report, Avian Influenza represented the largest segment.
Avian influenza, commonly known as bird flu, poses a significant threat to the global poultry industry due to its highly contagious nature and potential for rapid transmission within poultry flocks. This heightened risk has prompted poultry producers to prioritize avian influenza diagnostics as a proactive measure to protect their flocks. Additionally, avian influenza has garnered substantial attention from governments and international organizations due to its zoonotic potential, meaning it can be transmitted from birds to humans. This dual threat to animal and human health has led to stringent monitoring and control measures, further driving the demand for avian influenza diagnostics to ensure early detection and containment. Moreover, avian influenza outbreaks can result in devastating economic losses, including mass culling of infected birds, trade restrictions, and decreased consumer confidence in poultry products. Therefore, the economic implications of avian influenza outbreaks have incentivized poultry producers to invest significantly in avian influenza diagnostics as part of their risk mitigation strategies.
ELISA test
PCR Test
Others
ELISA test holds the largest share in the industry
A detailed breakup and analysis of the market based on the test type has also been provided in the report. This includes ELISA test, PCR test, and others. According to the report, ELISA test accounted for the largest market share.
ELISA is renowned for its versatility and wide applicability in detecting a broad spectrum of poultry diseases, including avian influenza, Newcastle disease, and salmonellosis, among others. This versatility makes it a preferred choice for many poultry producers and diagnostic laboratories as a comprehensive diagnostic tool. Besides this, ELISA tests offer high sensitivity and specificity, ensuring accurate and reliable results. The poultry industry places a premium on precise disease detection to make informed decisions promptly, such as initiating disease control measures or treatment protocols. Furthermore, ELISA tests are relatively cost-effective when compared to some other diagnostic methods, making them an attractive option for poultry producers seeking efficient disease management without significantly increasing operational costs. Additionally, the well-established nature of ELISA technology, along with a wealth of validated assays, instills confidence in its effectiveness among industry professionals and regulatory bodies. This confidence in reliability of ELISA and its track record of successful disease management contributes to its status as the largest segment in the market by test type.
Bacteriology
Parasitology
Virology
Bacteriology represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the service. This includes bacteriology, parasitology, and virology. According to the report, bacteriology represented the largest segment.
Bacteria play a pivotal role in poultry health, as bacterial infections can quickly spread within flocks and lead to severe economic losses. Bacteriology services encompass the isolation, identification, and characterization of bacterial pathogens responsible for various poultry diseases. This includes common issues like Salmonella and E. coli infections, which have significant implications for both poultry health and food safety. Moreover, food safety regulations and consumer demand for safe poultry products have intensified the focus on bacterial pathogens in poultry. As a result, poultry producers and processors rely heavily on bacteriology services to ensure that their products meet stringent safety standards and do not pose health risks to consumers. Furthermore, continuous research and innovation in bacteriology have led to the development of advanced diagnostic techniques, such as DNA sequencing and molecular methods, which offer higher specificity and sensitivity. This has further solidified position of bacteriology as the largest segment in the poultry diagnostics market by service, addressing critical needs for both animal health and public health.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest poultry diagnostics market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America has a well-established and highly industrialized poultry sector, with the United States being one of the largest poultry producers globally. This substantial poultry production requires rigorous disease management to ensure the health and safety of poultry flocks and the quality of poultry products, creating a substantial demand for diagnostic services and tools. Additionally, the region places a strong emphasis on food safety and consumer health. Stringent regulatory frameworks and consumer expectations for safe poultry products have spurred investments in advanced diagnostic technologies to detect and manage diseases effectively, thus supporting the growth of the poultry diagnostics market. Other than this, North America benefits from a mature healthcare and veterinary infrastructure, fostering the adoption of cutting-edge diagnostic methods. The presence of leading diagnostic companies, research institutions, and veterinary clinics further contributes to the availability and utilization of poultry diagnostics in the region. Furthermore, the proactive approach of North America to research and development in the poultry industry ensures a continuous flow of innovation in diagnostics, meeting the evolving needs of the sector.
Leading companies in the poultry diagnostics sector are heavily investing in R&D. They are developing innovative diagnostic tools and technologies that offer higher sensitivity, specificity, and speed in disease detection. This commitment to innovation ensures that poultry producers have access to state-of-the-art diagnostics to safeguard their flocks. Additionally, numerous key players are forming strategic partnerships with research institutions and veterinary organizations. These collaborations foster knowledge exchange, allowing for the development of cutting-edge diagnostic solutions. Partnerships also help in expanding market reach and ensuring the widespread adoption of advanced diagnostic technologies. Other than this, recognizing the global nature of the poultry industry, key players are expanding their presence in various regions. This involves setting up distribution networks, establishing subsidiaries, and entering emerging markets with high poultry production potential. By offering their diagnostic products and services worldwide, these companies are capitalizing on the growing demand for poultry diagnostics. Furthermore, tailoring diagnostic solutions to the specific needs of poultry producers is a notable strategy. Key players are offering customized diagnostic packages that address the unique challenges faced by different poultry operations. This approach enhances customer satisfaction and fosters long-term partnerships.
AgroBioTek Laboratories
BioChek B.V.
Bionote Co. Ltd.
Boehringer Ingelheim International GmbH
IDEXX Laboratories Inc.
MEGACOR Diagnostik GmbH
QIAGEN N.V.
Gezondheidsdienst voor Dieren B.V. (Royal GD)
Thermo Fisher Scientific Inc.
Zoetis Inc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
In 2022, IDEXX Laboratories Inc has announced the launch of a number of new diagnostic tests, as well as a new software application that helps farmers and producers to manage their poultry health. It has also introduced rapid testing methods and diagnostic assays that provide quick and accurate results for poultry diseases.
Qiagen, a leading player in the poultry diagnostics market, has focused on developing molecular diagnostic solutions for the poultry industry. It has launched advanced DNA and RNA-based tests to detect various pathogens and diseases in poultry.
Thermo Fisher Scientific Inc has been actively involved in the poultry diagnostics market. It has developed innovative solutions such as PCR-based testing kits and advanced diagnostic instruments to detect poultry diseases accurately.